Bioregenx (BRGX) Other Accumulated Expenses (2025 - 2026)
Bioregenx's (BRGX) quarterly Other Accumulated Expenses came in at $200000.0 in Q1 2026, little changed quarter-over-quarter from $200000.0 in Q4 2025.
Bioregenx (BRGX) Other Accumulated Expenses (2025 - 2026) Analysis & Trends
Bioregenx's Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $200000.0 for Q1 2026.
- On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $200000.0 in Q1 2026; TTM through Mar 2026 was $200000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $200000.0, changed N/A from the prior year.
- Other Accumulated Expenses steadied at $200000.0 in Q1 2026 per BRGX's latest filing, from $200000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $200000.0 in Q4 2025 and bottomed at $200000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 32.26 Bn | 24.95 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.62 Bn | 13.72 Bn | 482.22 Mn |
| 3 | Healthequity | 8.42 Bn | 8.16 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.96 Bn | 5.64 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn |
| 6 | MiniMed | 4.52 Bn | 4.23 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.47 Bn | 4.41 Bn | 216.84 Mn |
| 8 | Doximity | 3.97 Bn | 3.22 Bn | 125.97 Mn |
| 9 | Privia Health | 3.12 Bn | 2.70 Bn | - |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |